Background: In end-stage patients when all management options have been used, will often develop compromise of their airways as the cancer continues to progress. Endobronchial therapy options may help to relieve some of their symptoms, allowing improvement in their shortness of breath as they go home in combination with other palliative therapies. Objective: to compare the safety ; efficacy; and clinical outcome of endobronchial cryotherapy combined with chemotherapy and/ or radiotherapy versus chemo-radiotherapy alone on patients with Non small cell lung cancer. Patients and method(s): A prospective randomized clinical trial was carried out on 60 patients with different ages of both sexes, diagnosed as bronchogenic carcinoma non-small cell lung cancer type (NSCLC) . The patients attended the hospital in the chest department, Qena Faculty of Medicine, South Valley University. Assessment of the patients was done and randomly assigned into two groups. Group1 ,Include 30 patients subjected to chemotherapy , radiotherapy and endobronchial cryotherapy.Group 2 , Include include 30 patients subjected to chemotherapy and radiotherapy alone.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Evaluation of the clinical changes of the cases after procedure.
Timeframe: the symptoms were evaluated before therapy as a baseline; and evaluated 4 weeks after procedure.
Respiratory function test evaluation
Timeframe: Change from Baseline Spirometry done before management, was compared with that was done at 4 weeks after management.
Assessment of the overall survival
Timeframe: The overall survival was measured by the percentage of patients who still alive for 12 months after they were started the management.
Assessment of the performance status
Timeframe: The mean Karnofsky performance score was done before treatment as a baseline; and 4 weeks after treatment.